about
Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reactionPrevalence of herpesvirus DNA in MS patients and healthy blood donorsAnti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosisVirological analysis in the diagnosis of sudden children death: a medico-legal approach.Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severityRole of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis.Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysisHuman parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reactionPharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion.Classification of HHV-6A and HHV-6B as distinct viruses.HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.Metabolomic signatures associated with disease severity in multiple sclerosisMultimarker risk stratification approach at multiple sclerosis onset.Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid.Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.Real-time polymerase chain reaction detection of Neisseria meningitidis in formalin-fixed tissues from sudden deaths.Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum.CD46 expression and HHV-6 infection in patients with multiple sclerosis.Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.New life to an old treatment: pegylated Interferon beta 1a in the management of multiple sclerosis.Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.
P50
Q24673259-96DB0029-8B95-4A5B-A6E2-8F58BE88FCD6Q28208119-67F9F6F1-F342-443F-93E7-FD56C4FA27B8Q28245682-9D332468-7CD3-4D28-AD22-5D459F419B9DQ33341833-3762131F-241C-47E8-9CE7-752891FD53D5Q34414788-2F5D31E2-D328-422F-8394-B7D5EED9FFA6Q34421060-188AFC2C-5B7D-47C8-AD7C-F3E3402D837AQ34423587-EC770D18-E2D9-491D-ACBA-1A39C55818EAQ34457797-FE7ED628-A66F-42B2-A252-989736997DBCQ34545266-F57BCBA1-6667-4FE0-861A-C7451D137290Q34698295-0499F8C9-F5EC-4149-B5BF-FE621CA28F79Q35110787-5403CEF4-3B84-4C12-BC04-CFEED22698A4Q35555557-773F1956-8A26-4E49-80E4-09F3E1AEB451Q36092690-E86AD25B-901A-4860-ACD3-4F1F00889D4CQ36347638-1C0D0559-9454-4FCE-9A64-586AAAD26951Q36570863-E8FFA3F8-34CA-40B2-BE72-C79CFAF13D41Q37479915-329B54F1-EF0D-4E00-AA15-16A6842F6A9BQ37613281-14DF9A02-364F-48BF-9D84-D6EA2250040FQ38746684-327D1459-1685-4AE2-A718-62A82E03ACDFQ39159379-E7E61BD3-E220-4200-834B-EFDD6DE1312EQ40254432-E835B8D4-D5CD-4543-B4D9-CD4661474C0DQ40401876-87CEB306-B2B4-4A1C-A5C5-1A7DE4684808Q40502531-D9A75126-E90D-44FC-AB93-B51F73F7D0ECQ40938497-FCDAFE3D-21E0-475A-BDE0-BA32561562E2Q41004127-57942984-6A2B-4978-9F46-86F8DD46A963Q42516732-2D379933-2646-4DEF-ABC0-ED5DD1A057B9Q43780223-A6B2C9A8-55A5-44A9-87EC-77B9C62D58DFQ43991039-D8EE9B8B-B434-4B12-8450-3D9328156F2CQ45372857-2DFF5846-A5F6-44E6-B228-59F5C1D224B6Q45403289-D339A9A3-3C24-46E5-9007-00EA2FFA8881Q45801403-027FF0C4-763F-4B66-856A-E5DAAC4D04B3Q45919960-6AC00A5B-4A38-47BC-9B90-56571BF18444Q46239287-46FBDD63-4585-4742-9CEE-4F8FCA8B5E9BQ47761537-14F6B510-9A24-43C7-B440-3C33D50E1631Q48234976-B6B5B4A9-4AC5-46AE-90AD-1703B3DCC48BQ48585445-B3A34372-8A58-4D2E-AFED-DAAA80C518FFQ49922754-E100B406-2103-429F-A48E-20910425B7E0Q51004439-62F3A514-5AF8-4F82-A0BF-238B43AD335BQ52683687-8C4518BB-B801-463B-9BF8-989AB5D4DDD3Q54527978-DFF17C6B-D68E-48CC-869E-52846EB067F1Q54694965-2EF5EE9D-CB71-4EBC-A260-0DCA3C7D52C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberto Alvarez-Lafuente
@ast
Roberto Alvarez-Lafuente
@en
Roberto Alvarez-Lafuente
@es
Roberto Alvarez-Lafuente
@nl
type
label
Roberto Alvarez-Lafuente
@ast
Roberto Alvarez-Lafuente
@en
Roberto Alvarez-Lafuente
@es
Roberto Alvarez-Lafuente
@nl
prefLabel
Roberto Alvarez-Lafuente
@ast
Roberto Alvarez-Lafuente
@en
Roberto Alvarez-Lafuente
@es
Roberto Alvarez-Lafuente
@nl
P106
P21
P31
P496
0000-0002-3132-1486